Zobrazeno 1 - 10
of 52
pro vyhledávání: '"BÅRD MANNSÅKER"'
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-8 (2024)
Abstract Background Complex high-precision radiotherapy, such as stereotactic body radiotherapy (SBRT), should only be offered to patients with sufficiently long survival. In the context of bone metastases radiotherapy, low rates of treatment close t
Externí odkaz:
https://doaj.org/article/1122d4dd8fa546bd9c25a6057b2cb311
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-9 (2024)
Abstract Background This retrospective study analyzed the incidence of subsequent brain metastases after palliative radiotherapy or chemoradiation in patients with stage II/III non-small cell lung cancer (NSCLC). Risk factors for brain metastases dev
Externí odkaz:
https://doaj.org/article/de741a31c924434292a596c90fa26736
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background This study analyzed mortality after radiotherapy for bone metastases (287 courses). Endpoints such as treatment in the last month of life and death within 30, 35 and 40 days from start of radiotherapy were evaluated. Methods Diffe
Externí odkaz:
https://doaj.org/article/96e18b4084e64d83854307c72ae641b7
Autor:
Carsten Nieder, Luka Stanisavljevic, Siv Gyda Aanes, Bård Mannsåker, Ellinor Christin Haukland
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-7 (2022)
Abstract Background Established prognostic models, such as the diagnosis-specific graded prognostic assessment, were not designed to specifically address very short survival. Therefore, a brain metastases-specific 30-day mortality model may be releva
Externí odkaz:
https://doaj.org/article/cb452cee49e04f038805799d7948366b
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-6 (2020)
Abstract Introduction Esophagitis influences quality of life and might cause treatment interruption and hospitalization. Previous studies of risk factors focused on curative treatment for non-small cell lung cancer (NSCLC), which often involves conco
Externí odkaz:
https://doaj.org/article/f3555c3243564dcf821f0b4228b4f788
Autor:
Johanna Huun, Liv B. Gansmo, Bård Mannsåker, Gjertrud T. Iversen, Jan Sommerfelt-Pettersen, Jan Inge Øvrebø, Per E. Lønning, Stian Knappskog
Publikováno v:
Translational Oncology, Vol 10, Iss 5, Pp 806-817 (2017)
BACKGROUND: MDM2 is a negative regulator of p53 and is upregulated in numerous human cancers. While different MDM2 splice variants have been observed in both normal tissues and malignant cells, their functions are poorly understood. METHODS: We evalu
Externí odkaz:
https://doaj.org/article/984fb2741bd640468078af8a1510e84f
Autor:
Johanna Huun, Liv B. Gansmo, Bård Mannsåker, Gjertrud Titlestad Iversen, Jan Inge Øvrebø, Per E. Lønning, Stian Knappskog
Publikováno v:
BMC Cell Biology, Vol 18, Iss 1, Pp 1-9 (2017)
Abstract Background The murine double minute 2 (MDM2) is an oncogene and a negative regulator of the tumor suppressor protein p53. MDM2 is known to be amplified in numerous human cancers, and upregulation of MDM2 is considered to be an alternative me
Externí odkaz:
https://doaj.org/article/f268acc168ec49dc856cd974179968ac
Publikováno v:
International Journal of Circumpolar Health, Vol 76, Iss 1 (2017)
The aim of this study was to reduce barriers that prevent implementation of evidence-based recommendations about single-fraction palliative radiotherapy (PRT) and to demonstrate that single-fraction PRT yields similar outcomes as long-course treatmen
Externí odkaz:
https://doaj.org/article/e73bd7ca41384987a69567e1979a4cec
Publikováno v:
Reports of Practical Oncology and Radiotherapy. 28:47-53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a4765b165b2a054d11da5da194a0357
https://doi.org/10.5603/rpor.a2023.0013
https://doi.org/10.5603/rpor.a2023.0013
Publikováno v:
American Journal of Clinical Oncology. 46:178-182
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60936f970aeb97a920e37492f03a58d5
https://doi.org/10.1097/coc.0000000000000987
https://doi.org/10.1097/coc.0000000000000987